Literature DB >> 4124889

Treatment of ventricular arrhythmias with mexiletine (Kö 1173).

R G Talbot, J Nimmo, D G Julian, R A Clark, J M Neilson, L F Prescott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4124889     DOI： 10.1016/s0140-6736(73)92270-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  37 in total

Review 1.  Therapeutic drug monitoring of antiarrhythmic drugs.

Authors:  Gesche Jürgens; Niels A Graudal; Jens P Kampmann
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  The renal excretion of mexiletine (Kö 1173) under controlled conditions of urine pH.

Authors:  M A Kiddie; C M Kaye
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

3.  Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction.

Authors:  F Hagemeijer
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

4.  [Drug therapy of tachyarrhythmias (author's transl)].

Authors:  K Theisen
Journal:  Klin Wochenschr       Date:  1978-02-15

5.  Effect of rifampicin treatment on the kinetics of mexiletine.

Authors:  P J Pentikäinen; I H Koivula; H A Hiltunen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

7.  Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.

Authors:  M Arita; M Goto; Y Nagamoto; T Saikawa
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

Review 8.  Mexiletine: a review of its pharmacological properties and therapeutic efficacy in arrhythmias.

Authors:  C Y Chew; J Collett; B N Singh
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

9.  Efficacy of oral mexiletine in the prevention of exercise-induced ventricular ectopic activity.

Authors:  G Koch; B Lindström
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

10.  A case of mexiletine-induced hypersensitivity syndrome presenting as eosinophilic pneumonia.

Authors:  Sang-Pyo Lee; Sang-Heon Kim; Tae Hyung Kim; Jang Won Sohn; Dong Ho Shin; Sung Soo Park; Ho Joo Yoon
Journal:  J Korean Med Sci       Date:  2009-12-29       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.